High-dose Mycophenolate Use at Vaccination Is Independently Associated With Breakthrough COVID-19 Among Lung Transplant Patients

Transplantation. 2022 May 1;106(5):e271-e274. doi: 10.1097/TP.0000000000004089. Epub 2022 Mar 1.

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
² Division of Infectious Disease and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
³ Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX.

No abstract available

Publication types

Letter

MeSH terms

COVID-19* / prevention & control
Humans
Immunosuppressive Agents / adverse effects
Lung Transplantation* / adverse effects
SARS-CoV-2
Vaccination

Substances

Immunosuppressive Agents